Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss linked to prostate enlargement; stress and family history important factors.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

PCOS is a major cause of infertility in women of childbearing age.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Acne is an important sign of androgen excess disorders in women.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.